Equasens: Stifel upgrades stock

(CercleFinance.com) - Stifel has upgraded Equasens shares from 'hold' to 'buy', with a target price raised from E66 to E83.
The broker also sees potential for the healthcare software company's share price to double over the next five years.

Amongst reasons for its upgrade, the broker mentions improved growth and market dynamics, new product launches, European expansion into major markets, first-rate profitability and an attractive valuation.

At the dawn of a change in momentum, with growth set to accelerate in the second half of 2024, we believe there is a great opportunity to invest in a low-risk, high-quality company for the long term, it adds.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.